{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:20:56Z","timestamp":1775006456825,"version":"3.50.1"},"reference-count":48,"publisher":"Wiley","issue":"s380","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":4862,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1994,5]]},"abstract":"<jats:p>Acute extrapyramidal syndromes (EPS) are one of the major limitations to effective neuroleptic treatment. These disorders have both motor (objective) and mental (subjective) aspects, which must be considered in any evaluation and differential diagnosis of treatment\u2010related side effects. The disorders of akathisia, acute dystonia and parkinsonism have unique features that are best understood in the context of a careful assessment of patient characteristics, drug factors and temporal aspects. Though acute EPS are commonly explained on the basis of dopamine D, receptor antagonism, data from several lines of study raise important questions about this hypothesis. The roles of receptor subtype specificity, brain region selectivity and ratios of different receptor subtype antagonism are discussed. New and novel antipsychotic drugs with low rates of EPS are important clinical advancements that will increase patients' ability to participate in therapy and rehabilitation and thus improve their quality of life.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1994.tb05826.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:58:55Z","timestamp":1187873935000},"page":"14-20","source":"Crossref","is-referenced-by-count":60,"title":["Motor and mental aspects of acute extrapyramidal syndromes"],"prefix":"10.1111","volume":"89","author":[{"given":"D. E.","family":"Casey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"155","volume-title":"Discoveries in biological psychiatry","author":"Deniker P.","year":"1984"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195610000-00005"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-73280-5_7"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790320042006"},{"key":"e_1_2_1_6_2","first-page":"21","volume-title":"Drug\u2010induced movement disorders","author":"Casey DE","year":"1992"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1981.tb02460.x"},{"key":"e_1_2_1_8_2","first-page":"139","volume-title":"Disorders of movement in psychiatry and neurology","author":"Casey DE","year":"1992"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/07067437720176S213"},{"key":"e_1_2_1_10_2","first-page":"67","volume-title":"Disorders of movement in psychiatry and neurology","author":"Casey DE","year":"1992"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426532"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421217"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1990.tb05297.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790090075012"},{"key":"e_1_2_1_15_2","first-page":"89","article-title":"Implications of recent research on dopamine D1 and D2 receptor subtypes in relation to schizophrenia and neuroleptic drug action","volume":"2","author":"Waddington JL","year":"1989","journal-title":"Neurosci Neuropsychiatry"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244811"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244960"},{"key":"e_1_2_1_18_2","first-page":"1","volume-title":"Neurology and neurobiology, Volume 42C. Progress in catecholamine research, Part C: Clinical aspects","author":"Gerlach J","year":"1988"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244961"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820070032005"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760130040006"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426315"},{"key":"e_1_2_1_23_2","first-page":"238","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D\u20101, D\u20102 and serotonin pKi values","volume":"251","author":"Meltzer HY","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426037"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198602000-00010"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90135-9"},{"key":"e_1_2_1_27_2","first-page":"457","article-title":"Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates","volume":"25","author":"Casey DE","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_28_2","first-page":"47","article-title":"Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics","volume":"27","author":"Casey DE","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(91)90562-9"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00443404"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.3.412"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00178501"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00735822"},{"key":"e_1_2_1_34_2","first-page":"1411","volume-title":"Psychopharmacology: the third generation of progress","author":"Casey DE","year":"1987"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(91)90029-Q"},{"key":"e_1_2_1_36_2","first-page":"1021","volume-title":"Psychopharmacology: a generation of progress","author":"Sovner R","year":"1978"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879100400408"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1961.03040120016004"},{"key":"e_1_2_1_39_2","first-page":"164","article-title":"Anticholinergic prophylaxis of acute haloperidol induced dystonic reactions","volume":"7","author":"Boyer WF","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_40_2","first-page":"106","volume-title":"Disorders of movement in psychiatry and neurology","author":"Casey DE","year":"1992"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.7.869"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198710000-00011"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.1.85"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442559"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433493"},{"key":"e_1_2_1_46_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpsyc.1988.01800250095013","article-title":"Significance of neuroleptic dose and plasma level in pharmacological treatment of psychosis","volume":"45","author":"Baldessarini RJ","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_2_1_47_2","unstructured":"CaseyDE Aaes\u2010JorgensenT.Relationships between neuroleptic drug dose blood level and extrapyramidal syniptoms in cebus monkeys.Proc Soc Biol Psychiatry1988:250(abstract)."},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432736"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(93)90288-O"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1994.tb05826.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1994.tb05826.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:04:55Z","timestamp":1695801895000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1994.tb05826.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,5]]},"references-count":48,"journal-issue":{"issue":"s380","published-print":{"date-parts":[[1994,5]]}},"alternative-id":["10.1111\/j.1600-0447.1994.tb05826.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1994.tb05826.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,5]]}}}